GENE ONLINE|News &
Opinion
Blog

2022-11-15| In-DepthSpecial

Walmart To Settle Opioid Lawsuits with $3.1 Billion, U.S. Government Mulls OTC Naloxone

by Reed Slater
Share To
In an effort to close the door on its thousands of opioid lawsuits, Walmart announced a sweeping nationwide settlement framework, agreeing to pay $3.1 billion to resolve all lawsuits by state, local, and tribal governments. The retail behemoth said the payments would significantly aid the fight against opioids. On the same day, the FDA and the Department of Health and Human Resources (HHS) published a proposal to transition naloxone, a treatment used to reverse the effects of opioid overdose, to over-the-counter medication.

It's free! Log in now to read

LATEST
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
EVENT
Scroll to Top